# Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L

> **NCT06539429** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Anterogen Co., Ltd.** · enrollment: 6 (estimated)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **BIOLOGICAL:** ANT-301

## Key facts

- **NCT ID:** NCT06539429
- **Lead sponsor:** Anterogen Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-22
- **Primary completion:** 2026-05-15
- **Final completion:** 2026-05-15
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06539429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06539429, "Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06539429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*